https://www.selleckchem.com/pr....oducts/deferoxamine-
In contrast, neither ramelteon (OR 7.95, 95% CI 0.72-87.9, p = 0.09) nor suvorexant (OR 0.25, 95% CI 0.06-1.06, p = 0.06) were significantly associated with fall incidents. Thus, benzodiazepine receptor agonists, but not ramelteon or suvorexant, showed significant association with fall incidents. Therefore, special care should be taken especially when benzodiazepine receptor agonists are administrated to elderly subjects. In contrast, fall risk may be much less in patients treated with ramelteon or suvorexant. These result
Like
Comment
Share
